Healthcare & Medical Devices Global On demand · 24-48h

Global Sterile Venous Blood Collection Tube Market Strategic Research Report

Global Sterile Venous Blood Collection Tube Market Strategic…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Sterile Venous Blood Collection Tube Market
$4.68B2025
7.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, Others

By Application: Hospital & Clinic, Third-Party Laboratory, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BD, Terumo, GBO, Nipro, Cardinal Health, Sekisui, Sarstedt, FL Medical, Hongyu Medical, Improve Medical, TUD, Sanli Medical, Gong Dong Medical, CDRICH, Xinle Medical, Lingen Precision Medical, WEGO, Kang Jian Medical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 126 pages
Market size 2025
$4.68B
Billion USD
Forecast CAGR
7.3%
2025-2032
Forecast 2032
$7.7B
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Sterile Venous Blood Collection Tube market size is predicted to grow from US$ 4,682 million in 2025 to US$ 7,600 million in 2032; it is expected to grow at a CAGR of 7.3% from 2026 to 2032.

Sterile Venous Blood Collection Tube is a type of blood container used in venous blood collection process.By using the principle of negative pressure, with disposable venous blood collection needle, blood can be automatically drawn into tube, by adding different reagents to meet the requirements of the inspection, the color of the outer tube cap and the label can be used to distinguish, the product can absorb a certain amount of acceleration.

Market Drivers:

Growing demand for diagnostic testing: With an increase in the number of diagnostic tests for various diseases, including routine blood tests, infectious diseases, and chronic conditions like diabetes, the demand for plastic vacuum Sterile Venous Blood Collection Tube has risen. These tubes are essential for collecting, transporting, and processing blood samples in medical laboratories.

Increasing healthcare expenditure: As healthcare spending increases globally, especially in emerging markets, there is greater investment in healthcare infrastructure, diagnostic facilities, and equipment. This drives the demand for consumables like Sterile Venous Blood Collection Tube.

Advances in blood collection technology: Technological advancements in blood collection systems, such as pre-labeled, pre-sterilized, and easy-to-handle vacuum tubes, have improved the efficiency of blood collection processes in both clinical and laboratory settings. This has enhanced the adoption of plastic vacuum Sterile Venous Blood Collection Tube.

Rising awareness of preventive healthcare: As more individuals seek regular health check-ups and preventive care, the demand for diagnostic services and blood collection procedures has grown, further fueling the need for vacuum Sterile Venous Blood Collection Tube in medical settings.

Market Challenges:

Environmental concerns: Plastic waste generated from disposable medical products, including Sterile Venous Blood Collection Tube, is a significant environmental concern. The increased focus on reducing plastic waste and promoting eco-friendly alternatives may challenge the growth of the market as healthcare institutions seek more sustainable solutions.

High cost of raw materials: The cost of producing plastic vacuum Sterile Venous Blood Collection Tube can be affected by fluctuations in the prices of raw materials, such as plastic resins. Rising raw material costs can increase the overall production costs, potentially impacting profit margins for manufacturers and leading to higher prices for consumers.

Product recalls and regulatory challenges: Ensuring compliance with stringent regulatory standards for medical devices, such as Sterile Venous Blood Collection Tube, can be challenging. Any issues with product quality, safety, or contamination can result in recalls, impacting the reputation of manufacturers and creating disruptions in supply.

Increasing competition: The market for plastic vacuum Sterile Venous Blood Collection Tube is becoming more competitive with the entry of new manufacturers offering cost-effective products. Established players may face pressure to lower prices or innovate to maintain market share, which can affect profitability.

Risk of contamination and improper handling: While plastic vacuum Sterile Venous Blood Collection Tube are designed for safe blood collection, improper use or handling, such as inadequate sterilization or incorrect sealing, can lead to sample contamination or inaccurate diagnostic results. This poses a challenge for maintaining product quality and user confidence.

In the global market, the core manufacturers of Sterile Venous Blood Collection Tube are BD, GBO, Cardinal Health, etc. The top four players in the industry account for about 50% of the market share. Europe is the largest consumption place, with a consumption market share nearly 36.2% in 2023. Following Europe, North America is the second largest consumption place with the consumption market share of 28.7%.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Sterile Venous Blood Collection Tube market?

What factors are driving Sterile Venous Blood Collection Tube market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sterile Venous Blood Collection Tube market opportunities vary by end market size?

How does Sterile Venous Blood Collection Tube break out by Type, by Application?

This report presents a comprehensive overview of the global Sterile Venous Blood Collection Tube market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Serum Separating Tubes
  • EDTA Tubes
  • Plasma Separation Tubes
  • Others

Segment by Application

  • Hospital & Clinic
  • Third-Party Laboratory
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Sterile Venous Blood Collection Tube market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital & Clinic, Third-Party Laboratory, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Sterile Venous Blood Collection Tube Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$4.68B
2025
Forecast
$7.7B
2032
CAGR
7.3%
2025–2032
リージョン
5
global
Key companies
BDTerumoGBONiproCardinal HealthSekisuiSarstedtFL Medical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Serum Separating TubesEDTA TubesPlasma Separation TubesOthers
By Application
Hospital & ClinicThird-Party LaboratoryOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Serum Separating Tubes
  • 3.1.3 EDTA Tubes
  • 3.1.4 Plasma Separation Tubes
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital & Clinic
  • 4.1.3 Third-Party Laboratory
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BD
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Terumo
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 GBO
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Nipro
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Cardinal Health
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Sekisui
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Sarstedt
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 FL Medical
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Hongyu Medical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Improve Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 TUD
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Sanli Medical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Gong Dong Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 CDRICH
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Xinle Medical
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Lingen Precision Medical
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 WEGO
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Kang Jian Medical
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Sterile Venous Blood Collection Tube market?
The global Sterile Venous Blood Collection Tube market is estimated at US$ 4.68 billion in 2025 (base year) and is projected to reach US$ 7.6 billion by 2032.
What is the forecast CAGR for the Sterile Venous Blood Collection Tube market?
The market is expected to grow at a CAGR of 7.3% from 2026 to 2032, expanding from US$ 4.68 billion in 2025 to US$ 7.6 billion in 2032, roughly 1.6 times its base-year value.
What is Sterile Venous Blood Collection Tube?
Sterile Venous Blood Collection Tube is a type of blood container used in venous blood collection process.By using the principle of negative pressure, with disposable venous blood collection needle, blood can be automatically drawn into tube, by adding different reagents to meet the requirements of the inspection, the color of the outer tube cap and the label can be used to distinguish, the product can absorb a certain amount of acceleration.
What are the main segments of the Sterile Venous Blood Collection Tube market by type?
By type, the market is segmented into Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes and Others.
Which applications drive demand in the Sterile Venous Blood Collection Tube market?
Key applications covered include Hospital & Clinic, Third-Party Laboratory and Others.
Who are the key players in the Sterile Venous Blood Collection Tube market?
Key players profiled include BD, Terumo, GBO, Nipro, Cardinal Health, Sekisui, Sarstedt and FL Medical, among 18 companies covered in total.
Which regions and countries are covered for Sterile Venous Blood Collection Tube?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Sterile Venous Blood Collection Tube market?
This drives the demand for consumables like Sterile Venous Blood Collection Tube.
What challenges does the Sterile Venous Blood Collection Tube market face?
The increased focus on reducing plastic waste and promoting eco-friendly alternatives may challenge the growth of the market as healthcare institutions seek more sustainable solutions.
Who should buy the Sterile Venous Blood Collection Tube market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital & Clinic, Third-Party Laboratory and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Sterile Venous Blood Collection Tube market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.